Global healthcare company Johnson & Johnson is planning to start a Phase-3 clinical trial of its Covid-19 vaccine ahead of its original schedule, potentially in late September, said a top executive of the company. J&J announced its lead Covid-19 vaccine candidate on March 30.
from US News Headlines, Latest USA News, America Breaking News - Times of India https://ift.tt/2ZEs7el
from US News Headlines, Latest USA News, America Breaking News - Times of India https://ift.tt/2ZEs7el
Comments
Post a Comment